Toshihiro Matsukawa
Overview
Explore the profile of Toshihiro Matsukawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyashita N, Onozawa M, Kasahara K, Matsukawa T, Onodera Y, Suzuki K, et al.
Cancer Sci
. 2025 Feb;
PMID: 39905783
In this study, the mechanisms of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia (CML) were investigated focusing additional sex combs-like 1 (ASXL1) gene mutations and their downstream effects....
2.
Nakazato S, Takashima S, Matsukawa T, Anan T, Ujiie H, Matsuno Y
J Dermatol
. 2024 Dec;
PMID: 39698754
No abstract available.
3.
Matsukawa T, Onozawa M, Kondo T, Kanaya M, Hidaka D, Ota S, et al.
Ann Hematol
. 2024 Nov;
103(12):5333-5340.
PMID: 39614924
Acute myeloid leukemia (AML) is an aggressive hematological malignancy with genetic alterations. The FMS-like tyrosine kinase 3 (FLT3) gene is frequently mutated in adult de novo AML, with two types...
4.
Kimura H, Onozawa M, Matsukawa T, Goto H, Kondo T, Teshima T
Exp Hematol
. 2024 Mar;
134:104208.
PMID: 38548144
Germline mutations of THPO were reported as causes of hereditary thrombocythemia. Six previously reported distinct sites of the mutation were clustered at the 5`-untranslated region or the exon 3 splicing...
5.
Miyashita N, Onozawa M, Matsukawa T, Mori A, Hidaka D, Minauchi K, et al.
Br J Haematol
. 2024 Jan;
204(4):1549-1553.
PMID: 38238885
No abstract available.
6.
Kimura H, Onozawa M, Hashiguchi J, Hidaka D, Kanaya M, Matsukawa T, et al.
Ann Hematol
. 2023 Nov;
103(1):89-96.
PMID: 37962621
Thrombopoietin (THPO) is an essential factor for platelet production. Hereditary thrombocythemia (HT) is caused by a germline mutation of THPO, MPL, or JAK2 and is inherited in an autosomal-dominant manner....
7.
Takenaka K, Fuji S, Matsukawa T, Uchida N, Kobayashi T, Tanaka M, et al.
Ann Hematol
. 2023 Nov;
103(1):285-296.
PMID: 37947825
Cytomegalovirus (CMV) infection is a major infectious complication following allogeneic hematopoietic cell transplantation (allo-HCT). Although letermovir (LMV) prophylaxis dramatically reduces the incidence of early clinically significant CMV (csCMV) infection, it...
8.
Vaswani P, Onozawa M, Hasegawa Y, Ohigashi H, Ara T, Matsukawa T, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1397-1399.
PMID: 37670048
No abstract available.
9.
Kimura H, Onozawa M, Yoshida S, Miyashita N, Yokoyama S, Matsukawa T, et al.
Ann Hematol
. 2023 Aug;
102(11):3103-3113.
PMID: 37597110
IKZF1 deletion is a recurrent genomic alteration in B-cell acute lymphoblastic leukemia (B-ALL) and is divided into dominant-negative (DN) and loss of function (LOF) deletions. The prognostic impact of each...
10.
Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, et al.
Eur J Haematol
. 2023 Jul;
111(4):620-627.
PMID: 37465857
Objectives: The cryptic fusion oncogene NUP98::NSD1 is known to be associated with FLT3-ITD mutation in acute myeloid leukemia (AML), and an independent poor prognostic factor in pediatric AML. However, there...